A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077) (clinicaltrials.gov) - Oct 1, 2025 - P1 | N=40 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P1 trial • Cytomegalovirus Infection • Pediatrics • Transplantation
|